130 related articles for article (PubMed ID: 9325479)
21. Does donor-recipient ABO incompatibility protect against relapse after allogeneic bone marrow transplantation in first remission acute myeloid leukemia?
Mehta J; Powles R; Sirohi B; Treleaven J; Kulkarni S; Saso R; Tait D; Singhal S
Bone Marrow Transplant; 2002 May; 29(10):853-9. PubMed ID: 12058235
[TBL] [Abstract][Full Text] [Related]
22. Acute disseminated encephalomyelitis (ADEM) after allogeneic bone marrow transplantation for acute myeloid leukemia.
Tomonari A; Tojo A; Adachi D; Iseki T; Ooi J; Shirafuji N; Tani K; Asano S
Ann Hematol; 2003 Jan; 82(1):37-40. PubMed ID: 12574963
[TBL] [Abstract][Full Text] [Related]
23. [Basedow disease occurring after allogeneic bone marrow transplantation for acute lymphoblastic leukemia].
Sasaki Y; Ito K
Rinsho Ketsueki; 2002 Sep; 43(9):833-5. PubMed ID: 12412287
[TBL] [Abstract][Full Text] [Related]
24. Autoimmune diseases and autoimmunity post-bone marrow transplantation.
Sherer Y; Shoenfeld Y
Bone Marrow Transplant; 1998 Nov; 22(9):873-81. PubMed ID: 9827815
[TBL] [Abstract][Full Text] [Related]
25. [Allogeneic bone marrow transplantation in children from related donors other than HLA-identical siblings].
Morimoto T; Hattori K; Yabe H; Yabe M; Hinohara T; Shimizu T; Matsumoto M; Hagihara M; Tsuji K; Kato S
Rinsho Ketsueki; 1998 Sep; 39(9):631-9. PubMed ID: 9796395
[TBL] [Abstract][Full Text] [Related]
26. Muscle-specific kinase antibody associated myasthenia gravis after bone marrow transplantation.
Heidarzadeh Z; Mousavi SA; Ostovan VR; Nafissi S
Neuromuscul Disord; 2014 Feb; 24(2):148-50. PubMed ID: 24314584
[TBL] [Abstract][Full Text] [Related]
27. [Eradication of adult T-cell leukemia cells and maintenance of remission by the graft-versus-leukemia effect after allogeneic bone marrow transplantation].
Ota K; Hashino S; Shimizu K; Yonezumi M; Chiba K; Kondo T; Suzuki S; Imamura M; Asaka M
Rinsho Ketsueki; 2004 Sep; 45(9):1044-7. PubMed ID: 15510833
[TBL] [Abstract][Full Text] [Related]
28. Transmission of type 1 diabetes by bone marrow transplantation: a case report.
Mellouli F; Ksouri H; Torjmen L; Abdelkefi A; Ladeb S; Ben Othman T; Ben Hassen A; Béjaoui M
Pediatr Transplant; 2009 Feb; 13(1):119-22. PubMed ID: 18208435
[TBL] [Abstract][Full Text] [Related]
29. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
[TBL] [Abstract][Full Text] [Related]
30. Successful non-T-cell-depleted HLA-haploidentical 3-loci mismatched bone marrow transplantation.
Yagyu S; Kuroda H; Fujiki A; Tamura S; Iehara T; Morimoto A; Hosoi H; Sugimoto T; Imashuku S
Eur J Haematol; 2005 Jun; 74(6):529-32. PubMed ID: 15876259
[TBL] [Abstract][Full Text] [Related]
31. Unrelated donor marrow transplantation in childhood: a report from the Associazione Italiana Ematologia e Oncologia Pediatrica (AIEOP) and the Gruppo Italiano per il Trapianto Midollo Osseo (GITMO).
Dini G; Cancedda R; Giorgiani G; Porta F; Messina C; Uderzo C; Pession A; Fagioli F; La Nasa G; Arcese W; Pollichieni S; Zecca M; Lanino E; Mazzolari E; Cesaro S; Balduzzi A; Rondelli R; Vassallo E; Cappelli B; Locatelli F;
Haematologica; 2002 Aug; 87(8 Suppl):51-7. PubMed ID: 12412391
[TBL] [Abstract][Full Text] [Related]
32. Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination.
Carlens S; Ringdén O; Aschan J; Hägglund H; Ljungman P; Mattsson J; Remberger M
Clin Transplant; 1998 Apr; 12(2):84-92. PubMed ID: 9575394
[TBL] [Abstract][Full Text] [Related]
33. Allogeneic bone marrow transplantation with non-T-cell-depleted marrow from two HLA-antigen-mismatched related donors.
Ogawa H; Ikegame K; Kawakami M; Taniguchi Y; Oka Y; Kawase I
Haematologica; 2004 Mar; 89(3):373-5. PubMed ID: 15020286
[TBL] [Abstract][Full Text] [Related]
34. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
Keever-Taylor CA; Bredeson C; Loberiza FR; Casper JT; Lawton C; Rizzo D; Burns WH; Margolis DA; Vesole DH; Horowitz M; Zhang MJ; Juckett M; Drobyski WR
Biol Blood Marrow Transplant; 2001; 7(11):620-30. PubMed ID: 11760150
[TBL] [Abstract][Full Text] [Related]
35. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Ringdén O; Labopin M; Gorin NC; Le Blanc K; Rocha V; Gluckman E; Reiffers J; Arcese W; Vossen JM; Jouet JP; Cordonnier C; Frassoni F
J Clin Oncol; 2004 Feb; 22(3):416-23. PubMed ID: 14691124
[TBL] [Abstract][Full Text] [Related]
36. Myasthenia gravis and polymyositis as manifestations of chronic graft-versus-host-disease.
Tse S; Saunders EF; Silverman E; Vajsar J; Becker L; Meaney B
Bone Marrow Transplant; 1999 Feb; 23(4):397-9. PubMed ID: 10100585
[TBL] [Abstract][Full Text] [Related]
37. Myasthenia gravis after allogeneic bone marrow transplantation for lymphoblastic lymphoma.
Dowell JE; Moots PL; Stein RS
Bone Marrow Transplant; 1999 Dec; 24(12):1359-61. PubMed ID: 10627649
[TBL] [Abstract][Full Text] [Related]
38. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft.
Herrera C; Torres A; García-Castellano JM; Roman J; Martin C; Serrano J; Falcon M; Alvarez MA; Gomez P; Martinez F
Bone Marrow Transplant; 1999 Mar; 23(5):443-50. PubMed ID: 10100557
[TBL] [Abstract][Full Text] [Related]
39. [FK506 for the prophylaxis of graft-versus-host-disease after bone marrow transplantation from HLA-genotypically mismatched unrelated donor].
Nishida T; Haneda M; Kanie T; Murata M; Hamaguchi M; Minami S; Kodera Y
Rinsho Ketsueki; 1998 Aug; 39(8):574-9. PubMed ID: 9785975
[TBL] [Abstract][Full Text] [Related]
40. [Acute myelogenous leukemia with mediastinal and subcutaneous emphysema following chronic GVHD after allogeneic bone marrow transplantation].
Doki N; Irisawa H; Saito Y; Sakura T; Miyawaki S
Rinsho Ketsueki; 2005 Sep; 46(9):1038-43. PubMed ID: 16440761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
